Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 205,730
  • Shares Outstanding, K 21,565
  • Annual Sales, $ 32,530 K
  • Annual Income, $ -410 K
  • 60-Month Beta 1.10
  • Price/Sales 6.65
  • Price/Cash Flow 71.57
  • Price/Book 2.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.70 +42.39%
on 03/16/20
18.38 -48.10%
on 03/05/20
-7.33 (-43.45%)
since 03/03/20
3-Month
6.70 +42.39%
on 03/16/20
20.60 -53.69%
on 02/19/20
-2.83 (-22.88%)
since 01/03/20
52-Week
4.71 +102.46%
on 05/21/19
20.60 -53.69%
on 02/19/20
+3.69 (+63.08%)
since 04/03/19

Most Recent Stories

More News
Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing ("NGS") solutions, today announced the launch of...

FLGT : 9.54 (-4.89%)
Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results

Fourth Quarter 2019 Results:

FLGT : 9.54 (-4.89%)
Fulgent Genetics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 10, 2020 / Fulgent Genetics, Inc. (NASDAQ:FLGT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at 4:30...

FLGT : 9.54 (-4.89%)
Fulgent Genetics Announces Promotion of Brandon Perthuis to Chief Commercial Officer

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing ("NGS") solutions, today announced the promotion...

FLGT : 9.54 (-4.89%)
FULGENT GENETIC (FLGT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

FULGENT GENETIC (FLGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FLGT : 9.54 (-4.89%)
What's in Store for Fulgent Genetics (FLGT) Q4 Earnings?

Fulgent Genetics' (FLGT) fourth-quarter 2019 earnings are likely to reflect top-line growth and elevated test volumes.

BAX : 81.42 (-0.97%)
HQY : 41.09 (-6.38%)
NVRO : 93.96 (-1.38%)
FLGT : 9.54 (-4.89%)
5 Top-Ranked Stocks Beating the Market at Midway Q1

Better-than-expected earnings, positive development in the U.S.-China trade relationship, China stimulus measures, easing policies and slew of upbeat economic data buoyed the stocks.

CYH : 2.82 (-9.32%)
ENPH : 28.69 (-4.11%)
TNDM : 61.35 (-4.54%)
FLGT : 9.54 (-4.89%)
APLT : 31.86 (+2.61%)
Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company") today announced that it will release its fourth quarter and full year 2019 financial results after the market closes on Tuesday...

FLGT : 9.54 (-4.89%)
Zacks.com featured highlights include: AQN, IDN, FLGT and SMED

Zacks.com featured highlights include: AQN, IDN, FLGT and SMED

SMED : 7.26 (-6.56%)
FLGT : 9.54 (-4.89%)
AQN : 12.61 (unch)
IDN : 2.11 (-21.85%)
4 Breakout Stocks for Explosive Returns

Picking breakout stocks is one of the most favored methods for those utilizing an active investing approach since this strategy offers the scope of superlative returns.

SMED : 7.26 (-6.56%)
FLGT : 9.54 (-4.89%)
IDN : 2.11 (-21.85%)
AQN : 12.61 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade FLGT with:

Business Summary

Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools...

See More

Key Turning Points

2nd Resistance Point 10.57
1st Resistance Point 10.05
Last Price 9.54
1st Support Level 9.01
2nd Support Level 8.49

See More

52-Week High 20.60
Fibonacci 61.8% 14.53
Fibonacci 50% 12.66
Fibonacci 38.2% 10.78
Last Price 9.54
52-Week Low 4.71

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar